Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam versus indomethacin for prevention of heterotopic ossification after total hip arthroplasty
ChiCTR-OCH-12002364Phase 4Completed
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of meloxicam and indomethacin in ectopic ossification (HO) (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Incidence of heterotopic ossification. Started Aug 2010; status: completed.
02
Drugs
meloxicamindomethacin
03
Conditions
ectopic ossification (HO)
Beyond the preview
Go deeper on ChiCTR-OCH-12002364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-12002364.